Cancer

Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation

Published in AIDS Weekly and Law, April 17th, 2008

At the same time that medical science is making possible new therapies for treating AIDS, cancer, and other once fatal diseases, a new report finds major shortcomings in the way clinical trials are designed, carried out and funded in the U.S. with serious implications for the outcomes of medical research studies.

The result of the multi-year EDICT (Eliminating Disparities in Clinical Trials) Initiative conducted by the Chronic Disease Prevention and Control Research Center (CDPCRC) at Baylor College of Medicine in Houston and the Intercultural Cancer Council (ICC), the report provides an in-depth assessment of the state of clinical trials in the U.S. and offers a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly and Law

Source: AIDS Weekly and Law (2008-04-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry